Application of the use of high‐throughput technologies to the determination of protein structures of bacterial and viral pathogens

The Structural Proteomics In Europe (SPINE) programme is aimed at the development and implementation of high‐throughput technologies for the efficient structure determination of proteins of biomedical importance, such as those of bacterial and viral pathogens linked to human health. Despite the challenging nature of some of these targets, 175 novel pathogen protein structures (∼220 including complexes) have been determined to date. Here the impact of several technologies on the structural determination of proteins from human pathogens is illustrated with selected examples, including the parallel expression of multiple constructs, the use of standardized refolding protocols and optimized crystallization screens.

[1]  A. Desmyter,et al.  Receptor-Binding Protein of Lactococcus lactis Phages: Identification and Characterization of the Saccharide Receptor-Binding Site , 2006, Journal of bacteriology.

[2]  S. Cusack,et al.  The monomeric dUTPase from Epstein-Barr virus mimics trimeric dUTPases. , 2005, Structure.

[3]  G. Schneider,et al.  Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis Is a Sulfite Reductase with a Covalent Cys-Tyr Bond in the Active Site* , 2005, Journal of Biological Chemistry.

[4]  Richard S. P. Horler,et al.  An ATP‐binding cassette‐type cysteine transporter in Campylobacter jejuni inferred from the structure of an extracytoplasmic solute receptor protein , 2005, Molecular microbiology.

[5]  J. Betton,et al.  High throughput cloning and expression strategies for protein production. , 2004, Biochimie.

[6]  C. Vilchèze,et al.  Characterization of Mycobacterium smegmatis Expressing the Mycobacterium tuberculosis Fatty Acid Synthase I (fas1) Gene , 2004, Journal of bacteriology.

[7]  E. K. Jagusztyn-Krynicka,et al.  Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. , 2004, Vaccine.

[8]  David I Stuart,et al.  The nsp9 Replicase Protein of SARS-Coronavirus, Structure and Functional Insights , 2004, Structure.

[9]  I. Bertini,et al.  Structural Basis for the Function of the N-terminal Domain of the ATPase CopA from Bacillus subtilis* , 2003, Journal of Biological Chemistry.

[10]  T. Kuiken,et al.  Emerging viral infections in a rapidly changing world , 2003, Current Opinion in Biotechnology.

[11]  Y. Guan,et al.  Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.

[12]  I. Bertini,et al.  A core mutation affecting the folding properties of a soluble domain of the ATPase protein CopA from Bacillus subtilis. , 2003, Journal of molecular biology.

[13]  G. Riccardi,et al.  Techniques and applications: The heterologous expression of Mycobacterium tuberculosis genes is an uphill road. , 2003, Trends in microbiology.

[14]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[15]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[16]  J. Peiris,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study , 2003, The Lancet.

[17]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[18]  David I. Stuart,et al.  A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results , 2003 .

[19]  David I. Stuart,et al.  A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation , 2003 .

[20]  M. Espinal,et al.  The global situation of MDR-TB. , 2003, Tuberculosis.

[21]  A. Rosato,et al.  Structural genomics of proteins involved in copper homeostasis. , 2003, Accounts of chemical research.

[22]  Jean-Louis Romette,et al.  An RNA cap (nucleoside‐2′‐O‐)‐methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization , 2002, The EMBO journal.

[23]  I. Bertini,et al.  Solution structure of the N-terminal domain of a potential copper-translocating P-type ATPase from Bacillus subtilis in the apo and Cu(I) loaded states. , 2002, Journal of molecular biology.

[24]  A. Alcamí,et al.  Expression of Secreted Cytokine and Chemokine Inhibitors by Ectromelia Virus , 2000, Journal of Virology.

[25]  I. Kurinov,et al.  X-ray crystallographic analysis of pokeweed antiviral protein-II after reductive methylation of lysine residues. , 2000, Biochemical and biophysical research communications.

[26]  B. Barrell,et al.  Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491 , 2000, Nature.

[27]  S. Salzberg,et al.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. , 2000, Science.

[28]  A. Alcamí,et al.  Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. , 1999, The Journal of general virology.

[29]  A. Alcamí,et al.  Vaccinia virus immune evasion , 1997, Immunological reviews.

[30]  S. Levy,et al.  Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon , 1997, Antimicrobial agents and chemotherapy.

[31]  J. Hannan,et al.  Factors responsible for the introduction and spread of Campylobacter jejuni infection in commercial poultry production , 1990, Veterinary Record.

[32]  N. Weiss,et al.  The role of poultry and meats in the etiology of Campylobacter jejuni/coli enteritis. , 1986, American journal of public health.

[33]  P. Kellam,et al.  Poxvirus genomes: a phylogenetic analysis. , 2004, The Journal of general virology.

[34]  G. Bernardi,et al.  Gene Expression, Amino Acid Conservation, and Hydrophobicity Are the Main Factors Shaping Codon Preferences in Mycobacterium tuberculosis and Mycobacterium leprae , 2000, Journal of Molecular Evolution.

[35]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[36]  Ivan Rayment,et al.  [12] Reductive alkylation of lysine residues to alter crystallization properties of proteins. , 1997, Methods in enzymology.